Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $10.87 in the last session, down -0.46% from day before closing price of $10.92. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 0.84 million shares were traded.
Ratios:
We take a closer look at RCKT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 6.05. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on December 30, 2024, initiated with a Outperform rating and assigned the stock a target price of $32.
On December 18, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $29.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when White Mark Andrew bought 2,824 shares for $10.96 per share.
Militello John sold 896 shares of RCKT for $9,300 on Jan 23 ’25. The insider now owns 48,414 shares after completing the transaction at $10.38 per share. On Jan 23 ’25, another insider, Militello John, who serves as the Officer of the company, bought 896 shares for $10.38 each.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $31.47, while it has fallen to a 52-week low of $9.33. The 50-Day Moving Average of the stock is -4.17%, while the 200-Day Moving Average is calculated to be -37.99%.
Shares Statistics:
A total of 106.34M shares are outstanding, with a floating share count of 98.64M. Insiders hold about 7.24% of the company’s shares, while institutions hold 100.38% stake in the company.
